|
|
41
|
|
|
5641BS
|
|
|
C ZID 1G INJ (EMC) CEFTAZIDIME (B)
|
|
|
CEFTAZIDIME
|
|
|
C ZID
|
|
|
1G VIAL
|
|
|
B
|
|
|
6.8
|
|
|
6.7958
|
|
|
1G
|
|
|
VIAL
|
|
|
28
|
|
|
VIAL
|
|
|
EMC
|
|
|
EMCURE PHARMACEUTICALS LTD
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
15
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
1
|
|
|
N
|
|
|
08120612
|
|
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
THIRD GEN CEPHALOSPORINS
|
|
|
|